Browsing by Author "Penelope Moore"
Now showing 1 - 20 of 20
- Results Per Page
- Sort Options
Item Aberrant innate immune profile associated with COVID19 mortality in Pretoria South Africa(ACADEMIC PRESS INC ELSEVIER SCIENCE) M van der Mescht; Z de Beer; H Steel; R Anderson; Penelope Moore; " "et al"Item Betavariant recombinant booster vaccine elicits broad crossreactive neutralization of SARSCoV2 including Omicron variantsDelphine Planas; Lin Peng; Lingyi Zheng; Florence Guivel-Benhassine; Jinal Bhiman; Penelope Moore; E et alItem Clearance of persistent SARSCoV2 associates with increased neutralizing antibodies in advanced HIV disease postART initiationF Karim; C Riou; M Bernstein; Zesuliwe Jule; Anne Von Gottberg; Penelope Moore; E et alItem Comparing the immune abnormalities in MISC to healthy children and those with inflammatory disease reveals distinct inflammatory cytokine production and a monofunctional T cell responseClaire Butters; N Benede; Thandeka Moyo-Gwete; Simone Richardson; Muki Shey; Frances Ayres; Nelia Manamela; Z Makhado; Penelope MooreItem Development of a TwoComponent Nanoparticle Vaccine Displaying an HIV1 Envelope Glycoprotein that Elicits Tier 2 Neutralising AntibodiesKegomoditswe Malebo; Jeremy Woodward; P Ximba; Qiniso Mkhize; Thandeka Moyo-Gwete; Penelope Moore; E et alItem Development of LIBRAseq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV1 vaccinesMatthew Vukovich; N Raju; P Kgagudi; Nelia Manamela; Alexandra Abu-Shmais; Simone Richardson; Penelope Moore; E et alItem Distinct T cell polyfunctional profile in SARSCoV2 seronegative children associated with endemic human coronavirus crossreactivityN Benede; M Tincho; A Walters; V Subbiah; Thandeka Moyo-Gwete; Penelope Moore; E et alItem Evaluating the antibody response elicited by diverse HIV envelope immunogens in the African green monkey Vervet modelThandeka Moyo-Gwete; Frances Ayres; N Mzindle; Z Makhado; Nelia Manamela; Simone Richardson; Dale Kitchin; Strauss van Graan; E et al; Penelope MooreItem Frequency kinetics and determinants of viable SARSCoV2 in bioaerosols from ambulatory COVID19 patients infected with the Beta Delta or Omicron variants(NATURE PUBLISHING GROUP) S Jaumdally; M Tomasicchio; A Pooran; A Esmail; Elizabeth Mayne; Penelope Moore; E et alItem A Global Collaborative Comparison of SARSCoV2 Antigenicity Across 15 LaboratoriesP Brangel; S Tureli; B Mühlemann; N Liechti; Tandile Hermanus; Prudence Diale; Carol Crowther; Simone Richardson; Jinal Bhiman; Penelope Moore; E et alItem In utero human cytomegalovirus infection is associated with increased levels of putatively protective maternal antibodies in nonprimary infection evidence for boosting but not protectionJeffrey Dorfman; Sashkia Balla; Jayani Pathirana; Michelle Groome; Shabir Madhi; Penelope MooreItem Isolation and characterization of IgG3 glycantargeting antibodies with exceptional crossreactivity for diverse viral families(PUBLIC LIBRARY SCIENCE) M Vukovich; A Shiakolas; K Lindenbergh; Robert Richardson; Nelia Manamela; Simone Richardson; Penelope Moore; E et alItem Protective efficacy of a plantproduced beta variant rSARSCoV2 VLP vaccine in golden Syrian hamstersYolandy Lemmer; R Chapman; Celia Abolnik; Tanya Smith; Tandile Hermanus; Penelope Moore; E et alItem Safety and immunogenicity of booster vaccination and fractional dosing with Ad26 COV2S or BNT162b2 in Ad26COV2Svaccinated participantsC Riou; Jinal Bhiman; Y Ganga; Shobna Sawry; Frances Ayres; R Baguma; Sashkia Balla; E et al; Nelia Manamela; Faeezah Patel; Thandeka Moyo-Gwete; Simone Richardson; Vera Rees; Penelope Moore; Lee FairlieItem Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing antiHIV1 monoclonal antibodies bNAbs given to HIV1 exposed uninfected neonates and infants study protocol for a phase I trial(BIOMED CENTRAL LTD) A Goga; Trisha Ramraj; Logashvari Naidoo; Brodie Daniels; Penelope Moore; Nonhlanhla Mkhize; E et alItem SARSCoV2 501YV2 escapes neutralization by South African COVID19 donor plasmaConstantinos Wibmer; Frances Ayres; Tandile Hermanus; Mashudu Madzivhandila; E et al; Bronwen Lambson; Anne Von Gottberg; Cheryl Cohen; Lynn Morris; Jinal Bhiman; Penelope MooreItem SARSCoV2 BA45 infection triggers more crossreactive FcRIIIa signalling and neutralization than BA1 in the context of hybrid immunity(AMER SOC MICROBIOLOGY) Simone Richardson; Nkululeko Mzindle; T Motlou; Nelia Manamela; M van der Mescht; Bronwen Lambson; Josie Everatt; D Amoako; E "et al"; Anne Von Gottberg; Nicole Wolter; Jinal Bhiman; Penelope Moore; Nelia ManamelaItem SARSCoV2 correlates of protection from infection against variants of concernK Sun; Jinal Bhiman; Stefano Tempia; Jacoba Kleynhans; Vimbai Madzorera; Qiniso Mkhize; Haajira Kaldine; M McMorrow; Nicole Wolter; Jocelyn Moyes; Maimuna Carrim; Neil Martinson; Kathleen Kahn; Limakatso Lebina; Jacques Du Toit; Anne Von Gottberg; Penelope Moore; Cheryl Cohen; Thulisa MkhenceleItem SARSCoV2 humoral immunity in people living with HIV1Boitumelo Motsoeneng; Jinal Bhiman; Simone Richardson; Penelope MooreItem SARSCoV2 Infections in a Triad of Primary School Learners Grades 17 Their Parents and Teachers in KwaZuluNatal South Africa Protocol for a CrossSectional and Nested CaseCohort StudyR Dassaye; T Chetty; B Daniels; Z Gaffoor; Penelope Moore; E et al